Previous Close | 1.5500 |
Open | 1.5100 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 1.4801 - 1.5500 |
52 Week Range | 1.4801 - 15.3000 |
Volume | |
Avg. Volume | 61,106 |
Market Cap | 2.68M |
Beta (5Y Monthly) | 0.43 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -19.6200 |
Earnings Date | May 13, 2024 - May 17, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 18.00 |
HOLMDEL, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), announced today that on April 17, 2024, it received a letter (the “Notification Letter”) from The Nasdaq Stock Market, LLC (“Nasdaq”) informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely fi
TICINO, Switzerland and HOLMDEL, N.J., April 09, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc.® (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, today announced that Switzerland’s Canton of Ticino (Ticino) has partnered with Asecus AG to implement BIO-key’s AuthControl Sentry login solution. In a significant enhancement to its digi
BIO-key International, Inc. (NASDAQ:BKYI) Q4 2023 Earnings Call Transcript April 2, 2024 BIO-key International, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, everyone. Thank you for standing by, and welcome to BIO-key International’s Fourth Quarter 2023 Conference […]